IP Verse

Starting Dose Of Pth Conjugates

Patent No. EP3793587 (titled "Starting Dose Of Pth Conjugates") was filed by Ascendis Pharma Bone Diseases on May 17, 2019. The application was issued on Jul 2, 2025.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICAL INDUSTRIES LTDApr 1, 2026VON KAUFFMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3793587

ASCENDIS PHARMA BONE DISEASES
Application Number
EP19724825A
Filing Date
May 17, 2019
Status
Granted And Under Opposition
May 29, 2025
Publication Date
Jul 2, 2025
External Links
Slate, Register , Google Patents